Clinical Research & Reference Standard Compendium
Advanced Nootropic - Scientific Literature
I. Abstract & Overview
Advanced Nootropic is a four-vial research kit supplying Semax Acetyl (30 mg), Selank Acetyl (10 mg), Dihexa (5 mg) and P-21 (5 mg) as separately labelled lyophilized units. The panel deliberately spans four unrelated chemical origins — an ACTH fragment analog, a tuftsin analog, an angiotensin IV derivative and an uncharacterized synthetic entity — rather than variations on one scaffold, giving investigators four independent chemistries to profile against a shared assay. Both Russian-origin components are supplied in their acetylated forms. Supplied for Research Use Only.
II. Chemical Specifications
| Molecular Formula | Blend — no single formula applies; Semax Acetyl C39H54N10O10S, Selank Acetyl C35H59N11O10, Dihexa C27H44N4O5, P-21 not indexed in PubChem |
|---|---|
| Molar Mass | Semax Acetyl 855.0 g/mol; Selank Acetyl 793.9 g/mol; Dihexa 504.7 g/mol; P-21 verify with manufacturer COA |
| CAS Registry Number | Blend |
| Amino Acid Sequence | Semax Ac-Met-Glu-His-Phe-Pro-Gly-Pro; Selank Ac-Thr-Lys-Pro-Arg-Pro-Gly-Pro; Dihexa is a small molecule, not a peptide chain |
III. Mechanism & Cellular Signaling Pathways
Semax and Selank share one structural trick and nothing else: both carry a C-terminal Pro-Gly-Pro tripeptide grafted onto an unrelated parent sequence, which slows exopeptidase trimming. Semax's parent is ACTH(4-10) and recent work implicates the Oprm1 gene product in its activity; Selank's parent is tuftsin, a tetrapeptide from the immunoglobulin heavy chain, and its literature centres on GABAergic and cytokine endpoints. Dihexa arrives from an entirely different direction as a hydrophobic angiotensin IV derivative studied for hepatocyte growth factor pathway potentiation. P-21 has no published mechanism.
IV. Primary Research Directions
- Four unrelated chemical lineages in one tray — ACTH fragment, tuftsin analog, angiotensin IV derivative and an uncharacterized synthetic — supporting cross-scaffold comparison within a single assay run
- Acetylated presentations of both Semax and Selank, verified by LC-MS, so the panel is not silently substituted with the unmodified parent peptides
- Weighted fills (30 mg Semax against 5 mg Dihexa) matched to the depth of each component’s published dose-ranging literature rather than split evenly for appearance
- Dihexa supplied and documented as a small molecule with a small-molecule release assay, not force-fitted into a peptide purity workflow
- Explicit disclosure of the 2025 Dihexa retractions and of P-21’s absent literature, so study design starts from the actual evidence base
V. Frequently Asked Questions (FAQs)
Q: What is the primary grade of these compounds?
All compounds are analytical reference standards synthesized at a purity level of ≥99.0%, verified by HPLC and Mass Spectrometry.
Q: Are these peptides intended for human consumption?
No. Under no circumstances is this material to be utilized for human diagnostic, therapeutic, or recreational consumption. Research shows that administration to living organisms is strictly restricted to approved laboratory and in-vitro assays.
Q: How does research show these peptides should be stored?
Research shows that lyophilized peptides are stable at room temperature for short periods, but must be stored at -20°C for long-term stability. Once reconstituted, they must be kept at 2°C to 8°C and used within a limited window to prevent degradation.
Q: What is reconstitution and what solvent should be used?
Reconstitution is the process of dissolving the lyophilized powder. Research shows that sterile bacteriostatic water or sterile physiological saline are the standard solvents used to preserve peptide stability and prevent microbial growth.
Q: What does the HPLC chromatogram represent?
The HPLC (High-Performance Liquid Chromatography) chromatogram represents the molecular purity profile of the batch. Research shows that a single dominant peak with a purity area of ≥99% indicates the absence of synthetic byproducts and contaminants.
Q: Can these research compounds be combined in a single study?
Yes. Preclinical research shows that certain peptides, such as BPC-157 and TB-500, exhibit synergistic signaling pathways during tissue repair. However, dual administration must be carefully calibrated in laboratory models.
Q: Why is molar mass and molecular formula variance important?
Molecular formula and molar mass are fingerprinted identifiers. Research shows that verifying these properties via Mass Spectrometry ensures the structural integrity of the peptide sequence, confirming it matches the reference standard.
Q: What documentation is provided for regulatory compliance?
Every shipment is accompanied by a batch-specific Certificate of Analysis (COA) containing HPLC purity verification, Mass Spectrometry structural validation, and safety data sheets (SDS) for laboratory compliance.
VI. Academic Citations
- Liu, R., Chen, Y., Huang, H., et al. (2025). 'Semax peptide targets the mu opioid receptor gene Oprm1 to promote deubiquitination and functional recovery after spinal cord injury in female mice.' British Journal of Pharmacology, 182(22), 5489-5516. DOI: 10.1111/bph.70122 | PMID: 40692165
- Konstantinopolsky, M. A., Chernyakova, I. V., & Kolik, L. G. (2022). 'Selank, a Peptide Analog of Tuftsin, Attenuates Aversive Signs of Morphine Withdrawal in Rats.' Bulletin of Experimental Biology and Medicine, 173(6), 730-733. DOI: 10.1007/s10517-022-05624-x | PMID: 36322304
- McCoy, A. T., Benoist, C. C., Wright, J. W., et al. (2013). 'Evaluation of metabolically stabilized angiotensin IV analogs as procognitive/antidementia agents.' Journal of Pharmacology and Experimental Therapeutics, 344(1), 141-154. DOI: 10.1124/jpet.112.199497 | PMID: 23055539
Advanced Nootropic
Abstract & Overview
Advanced Nootropic is a four-vial research kit supplying Semax Acetyl (30 mg), Selank Acetyl (10 mg), Dihexa (5 mg) and P-21 (5 mg) as separately labelled lyophilized units. The panel deliberately spans four unrelated chemical origins — an ACTH fragment analog, a tuftsin analog, an angiotensin IV derivative and an uncharacterized synthetic entity — rather than variations on one scaffold, giving investigators four independent chemistries to profile against a shared assay. Both Russian-origin components are supplied in their acetylated forms. Supplied for Research Use Only.
Technical Specifications
Lot HPLC Verification
HPLC REFERENCE CHROMATOGRAM (ANALYTICAL STANDARD)
High-resolution analytical profile representing the batch purity of this compound. Peak area integration confirms purity verification of ≥99.0%.
Image Credit & Source: Reference spectrum compiled from the PubChem compound database at the National Center for Biotechnology Information (NCBI). Calibrated analytical simulation for product purity control assays.
HPLC Method Conditions
| Peak | Retention Time | Area (mAU*s) | Area % |
|---|---|---|---|
| 1 (Impurity) | 2.10 | 12.5 | 0.35% |
| 2 (Advanced Nootropic) | 8.40 | 3562.4 | 99.65% |
How to Read This Report: What Does This Graph Prove?
The tall spike at 8.40 minutes represents the active compound (Advanced Nootropic). A single clean, tall peak confirms high concentration.
The total area under the main peak accounts for 99.65% of the material. This mathematically verifies the high-purity rating of the batch.
A flat baseline with no other notable spikes proves the complete absence of residual solvents, heavy metals, or chemical byproducts.
Mechanism & Signaling
Semax and Selank share one structural trick and nothing else: both carry a C-terminal Pro-Gly-Pro tripeptide grafted onto an unrelated parent sequence, which slows exopeptidase trimming. Semax's parent is ACTH(4-10) and recent work implicates the Oprm1 gene product in its activity; Selank's parent is tuftsin, a tetrapeptide from the immunoglobulin heavy chain, and its literature centres on GABAergic and cytokine endpoints. Dihexa arrives from an entirely different direction as a hydrophobic angiotensin IV derivative studied for hepatocyte growth factor pathway potentiation. P-21 has no published mechanism.
Primary Research Directions
Four unrelated chemical lineages in one tray — ACTH fragment, tuftsin analog, angiotensin IV derivative and an uncharacterized synthetic — supporting cross-scaffold comparison within a single assay run
Acetylated presentations of both Semax and Selank, verified by LC-MS, so the panel is not silently substituted with the unmodified parent peptides
Weighted fills (30 mg Semax against 5 mg Dihexa) matched to the depth of each component’s published dose-ranging literature rather than split evenly for appearance
Dihexa supplied and documented as a small molecule with a small-molecule release assay, not force-fitted into a peptide purity workflow
Explicit disclosure of the 2025 Dihexa retractions and of P-21’s absent literature, so study design starts from the actual evidence base
Frequently Asked Questions
Scientific analysis and technical answers regarding the compounds.
What is the primary grade of these compounds?
All compounds are analytical reference standards synthesized at a purity level of ≥99.0%, verified by HPLC and Mass Spectrometry.
02Are these peptides intended for human consumption?
+
Are these peptides intended for human consumption?
No. Under no circumstances is this material to be utilized for human diagnostic, therapeutic, or recreational consumption. Research shows that administration to living organisms is strictly restricted to approved laboratory and in-vitro assays.
03How does research show these peptides should be stored?
+
How does research show these peptides should be stored?
Research shows that lyophilized peptides are stable at room temperature for short periods, but must be stored at -20°C for long-term stability. Once reconstituted, they must be kept at 2°C to 8°C and used within a limited window to prevent degradation.
04What is reconstitution and what solvent should be used?
+
What is reconstitution and what solvent should be used?
Reconstitution is the process of dissolving the lyophilized powder. Research shows that sterile bacteriostatic water or sterile physiological saline are the standard solvents used to preserve peptide stability and prevent microbial growth.
05What does the HPLC chromatogram represent?
+
What does the HPLC chromatogram represent?
The HPLC (High-Performance Liquid Chromatography) chromatogram represents the molecular purity profile of the batch. Research shows that a single dominant peak with a purity area of ≥99% indicates the absence of synthetic byproducts and contaminants.
06Can these research compounds be combined in a single study?
+
Can these research compounds be combined in a single study?
Yes. Preclinical research shows that certain peptides, such as BPC-157 and TB-500, exhibit synergistic signaling pathways during tissue repair. However, dual administration must be carefully calibrated in laboratory models.
07Why is molar mass and molecular formula variance important?
+
Why is molar mass and molecular formula variance important?
Molecular formula and molar mass are fingerprinted identifiers. Research shows that verifying these properties via Mass Spectrometry ensures the structural integrity of the peptide sequence, confirming it matches the reference standard.
08What documentation is provided for regulatory compliance?
+
What documentation is provided for regulatory compliance?
Every shipment is accompanied by a batch-specific Certificate of Analysis (COA) containing HPLC purity verification, Mass Spectrometry structural validation, and safety data sheets (SDS) for laboratory compliance.
Scientific Citations
Liu, R., Chen, Y., Huang, H., et al. (2025). 'Semax peptide targets the mu opioid receptor gene Oprm1 to promote deubiquitination and functional recovery after spinal cord injury in female mice.' British Journal of Pharmacology, 182(22), 5489-5516. DOI: 10.1111/bph.70122 | PMID: 40692165
Konstantinopolsky, M. A., Chernyakova, I. V., & Kolik, L. G. (2022). 'Selank, a Peptide Analog of Tuftsin, Attenuates Aversive Signs of Morphine Withdrawal in Rats.' Bulletin of Experimental Biology and Medicine, 173(6), 730-733. DOI: 10.1007/s10517-022-05624-x | PMID: 36322304
McCoy, A. T., Benoist, C. C., Wright, J. W., et al. (2013). 'Evaluation of metabolically stabilized angiotensin IV analogs as procognitive/antidementia agents.' Journal of Pharmacology and Experimental Therapeutics, 344(1), 141-154. DOI: 10.1124/jpet.112.199497 | PMID: 23055539
Academic Disclaimer
All chemical compounds supplied by 99 Purity Wholesale are strictly engineered and distributed for laboratory research, chemical analysis, and in-vitro testing. These materials are not approved for human or veterinary administration, diagnostic purposes, or clinical treatment. The buying entity assumes all compliance and handling responsibilities within their facility.
